Industry Insights

Clinical Development Practices & Regulations

Clinical Development Practices & Regulations

Clinical Development Practices and Regulations are the main focus for our Q2 Industry Update. We also include important information about COVID-19, expertly compiled by Christina Hägglund, QA Manager, S-cubed Ltd. Read all the latest regulatory news here. You can download…
Clinical Trial Regulation, ICH E6(R2) & Brexit

Clinical Trial Regulation, ICH E6(R2) & Brexit

Clinical Trial Regulation, ICH E6(R2), Brexit and much more feature in our Q1 Industry Update, compiled by Christina Hägglund, QA Manager S-cubed Ltd. Read all the latest regulatory news here. You can download the pdf of this update here and…
Nitrosamines, TOPRA, Drug Development News

Nitrosamines, TOPRA, Drug Development News

Industry Insights for Q4 - 2019 Our latest regulatory updates for the final quarter of the year covers news from the FDA, EMA, important news about nitrosamines impurities, and much more. Christina Hägglund compiles the latest regulatory updates from around…
Global Harmonisation of Clinical Trials

Global Harmonisation of Clinical Trials

Industry Insights for Q3 - 2019 Our Q3 Industry Insights from Christina Hägglund provides an overview of everything you need to know about the latest regulatory updates from around the globe. Need advice or support? Then get in touch. Harmonising…
Latest News in Clinical Development Practices and Regulations

Latest News in Clinical Development Practices and Regulations

Industry Insights for Q2 - 2019 The second quarter has flown by and we are still living with the uncertainty of Brexit. However, Christina Hägglund can be relied upon to bring the latest updates from the global regulatory authorities. If…